Kestra Medical Technologies (KMTS) Other Accumulated Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Other Accumulated Expenses data on file, last reported at $6.1 million in Q1 2026.

• Quarterly Other Accumulated Expenses rose 76.94% year-over-year to $6.1 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $6.1 million (up 76.94% YoY) and the FY2025 annual result came in at $3.5 million, up 197.82% from the prior year.
• Other Accumulated Expenses grew to $6.1 million in Q1 2026 per KMTS's latest filing, from $5.3 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $6.1 million in Q1 2026 and bottomed at $1.2 million in Q2 2024.
• The 3-year median for Other Accumulated Expenses is $4.3 million (2025), against an average of $4.1 million.
• The widest annual swing landed in 2025, when Other Accumulated Expenses soared 197.82%; it then soared 76.94% in 2026.
• Tracing KMTS's Other Accumulated Expenses over 3 years: stood at $1.2 million in 2024, then soared by 348.87% to $5.3 million in 2025, then gained by 14.09% to $6.1 million in 2026.
• Per Business Quant, the three latest KMTS Other Accumulated Expenses figures stand at $6.1 million (Q1 2026), $5.3 million (Q4 2025), and $5.1 million (Q3 2025).

Peer Comparison